Clinical trial
Study With SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With IOP >= 21 mm Hg.
NCT01227291 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study With SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With IOP >= 21 mm Hg.
- Lead sponsor
- Sylentis, S.A.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- September 30, 2012
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.